| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/18/2009 | CN100469761C Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 03/18/2009 | CN100469376C Method of raising insulin excretion by capejasmine extract through specificity inhibition UCP2 |
| 03/18/2009 | CN100469372C Xindakang drip pill and preparation thereof |
| 03/18/2009 | CN100469363C Therapeutic combinations of fatty acids |
| 03/18/2009 | CN100469362C Composite amino acid freeze dried powder injection and its preparation process |
| 03/18/2009 | CN100469361C Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/17/2009 | USRE40667 [R-(R*R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof |
| 03/17/2009 | US7504522 e.g. 3-(2,4,4'-trichlorobenzhydryloxy)-N-(tert-butyl)azetidine-1-carboxamide; cannabinoid receptor antagonist; antidiabetic agent, antidepressant; eating disorders, obesity, nicotine addiction |
| 03/17/2009 | US7504433 e.g. (2-Methyl-4-{2-[3-methyl-5-(4-trifluoromethyl-phenyl)-thiophen-2-yl]-propylsulfanyl}-phenoxy)-acetic acid;peroximose proliferator activated receptor; antidiabetic agent,atherosclerosis |
| 03/17/2009 | US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 03/17/2009 | US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis |
| 03/17/2009 | US7504411 2,3,6-Trisubstituted-4-pyrimidone derivatives |
| 03/17/2009 | US7504402 bicyclo[2.2.2]-oct-1-yl-1,2,4-triazoles; type 2 diabetes, lipid disorders, obesity, atherosclerosis, metabolic syndrome, hyperglycemia, insulin resistance; increase insulin sensitivity in muscle, liver and adipose tissue by correction of the elevated plasma levels of glucose without causing hypoglycemia |
| 03/17/2009 | US7504398 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation |
| 03/17/2009 | US7504392 2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use |
| 03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
| 03/17/2009 | CA2502731C Sustained release composition for oral administration of drugs |
| 03/17/2009 | CA2429263C Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 03/17/2009 | CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 03/17/2009 | CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
| 03/17/2009 | CA2316351C Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |
| 03/12/2009 | WO2009033078A2 Compositions and methods for controlling cholesterol levels |
| 03/12/2009 | WO2009031920A1 Hypoglycemic agent and method for the production thereof |
| 03/12/2009 | WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN |
| 03/12/2009 | WO2009031691A1 Foodstuff of tablets or capsules |
| 03/12/2009 | WO2009031690A2 Foodstuff comprising an extract of a plant of the genus salacia and flavonoid |
| 03/12/2009 | WO2009031603A1 Fat absorption inhibiting composition |
| 03/12/2009 | WO2009030962A1 Bicyclic aryl and heteroaryl receptor modulators |
| 03/12/2009 | WO2009030931A1 Compound for controlling appetite |
| 03/12/2009 | WO2009030715A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |
| 03/12/2009 | WO2009029998A1 Retrometabolic compounds |
| 03/12/2009 | WO2009011617A3 ANNELATED AZAHETEROCYCLES COMPRISING PYRIMIDINE FRAGMENT, METHOD FOR THE PRODUCTION THEREOF AND (PI3Ks) KINASE INHIBITORS |
| 03/12/2009 | WO2008155668A3 Heteroarylamide pyrimidone compounds |
| 03/12/2009 | WO2008145524A3 4,4-disubstituted piperidine derivatives |
| 03/12/2009 | WO2008125945A3 3-amido-pyrrolo [3, 4-c] pyrazole-5 (1h, 4h, 6h) carbaldehyde derivatives as inhibitors of protein kinase c |
| 03/12/2009 | WO2008116185A3 Substituted pyrimidines as adenosine receptor antagonists |
| 03/12/2009 | WO2008035305A8 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia |
| 03/12/2009 | US20090069437 Compositions for Oral Transmucosal Delivery of Metformin |
| 03/12/2009 | US20090069434 Cystalline form VI of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| 03/12/2009 | US20090069432 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 03/12/2009 | US20090069373 Quinoline Acids |
| 03/12/2009 | US20090069348 Use of Inhibitors of the Renin-Angiotensin System |
| 03/12/2009 | US20090069338 Method for predicting skin sensitizing activity of compounds |
| 03/12/2009 | US20090069336 Pyrimidothiophene compounds |
| 03/12/2009 | US20090069329 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
| 03/12/2009 | US20090069326 (R)-3-{3,5-Dichloro-4'-[4-(2-fluoro-ethyl)-piperazine-1-carbonyl]-biphenyl-4-ylmethyl}-1-(4,4-difluoro-cyclohexyl)-pyrrolidin-2-one, used for the treatment of diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome and cognitive disorders |
| 03/12/2009 | US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity |
| 03/12/2009 | US20090069303 Phthalazinone derivatives |
| 03/12/2009 | US20090069301 Acridine and Quinoline Derivatives as Sirtuin Modulators |
| 03/12/2009 | US20090069284 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 03/12/2009 | US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds |
| 03/12/2009 | US20090069252 C-glycoside derivatives and salts thereof |
| 03/12/2009 | US20090069216 Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof |
| 03/12/2009 | US20090069215 Acylated Single Chain Insulin |
| 03/12/2009 | US20090068300 Pre- and post-workout formulations processes and supplement products thereby |
| 03/12/2009 | US20090068289 Formulation for menopausal women |
| 03/12/2009 | US20090068277 Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom |
| 03/12/2009 | US20090068264 Clinical Applications of Tetrahydrobiopterin, Lipoic Acid and Their Salts and Methods of Preparing Tetrahydrobiopterin Bis-Lipoate |
| 03/12/2009 | US20090068199 Methods for Treating and Detecting Beta-Cell Disease |
| 03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
| 03/12/2009 | US20090068147 Raav vector-based pro-opiomelanocortin compositions and methods of use |
| 03/12/2009 | US20090068145 Methods and Compositions Relating to Islet Cell Neogenesis |
| 03/12/2009 | US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION |
| 03/12/2009 | US20090068101 A1 Adenosine Receptor Antagonists |
| 03/12/2009 | DE102007042154A1 Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel Arylsulfonylaminomethyphosphonsäure derivatives, their preparation and their use as medicaments |
| 03/12/2009 | CA2698742A1 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
| 03/12/2009 | CA2698665A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 03/12/2009 | CA2698486A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |
| 03/12/2009 | CA2697930A1 Compound for controlling appetite |
| 03/11/2009 | EP2034018A1 Genetically modified animal and use thereof |
| 03/11/2009 | EP2034009A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects basing on cd3/cd28 costimulation |
| 03/11/2009 | EP2033972A1 Screening method for candidate drugs |
| 03/11/2009 | EP2033650A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor |
| 03/11/2009 | EP2033644A1 Spiroindene and spiroindane compounds |
| 03/11/2009 | EP2033634A1 Agent for increasing testosterone level |
| 03/11/2009 | EP2033631A2 Pravastatin pharmaceutical formulations and methods of their use |
| 03/11/2009 | EP2033526A1 Nutritional products comprising pomegranate extracts containing ellagitannins and their use |
| 03/11/2009 | EP2032594A1 Glycyrrhetinic acid derivatives |
| 03/11/2009 | EP2032571A1 3 -amino-imidazo[1, 2-a]pyridine derivatives as sglt inhibitors |
| 03/11/2009 | EP2032570A1 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 03/11/2009 | EP2032566A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 03/11/2009 | EP2032554A1 Piperidinyl pyrimidine derivatives |
| 03/11/2009 | EP2032546A1 Oxazole derivatives and their use in the treatment of diabetes and obesity |
| 03/11/2009 | EP1819332B1 Pyrrolopyridine-2-carboxylic acid amides |
| 03/11/2009 | EP1715878B1 Use of the lupinoside pa4 or a butanol fraction of an extract of pueraria tuberosa for the treatment of diabetes type 2 |
| 03/11/2009 | EP1696937B1 Prebiotic combination products |
| 03/11/2009 | EP1667770B1 Method for the production of derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro [3a,3,2][ 2]- benzazepine |
| 03/11/2009 | EP1611111B1 Process for resolving 2,4-diamino-3,6-dihydro-1,3,5-triazines, useful for the treatment of disorders associated with insulin resistance syndrome |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1429845B1 Treatment or prophylaxis of insulin-producing cell graft rejection |
| 03/11/2009 | EP1411899B1 Taste masking composition |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1302476B1 Reduced fk228 and use thereof |
| 03/11/2009 | CN101384595A Salt of CD 80 antagonist |
| 03/11/2009 | CN101384594A Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 03/11/2009 | CN101384275A Dissolution aids for oral peptide delivery comprising a biguanide |
| 03/11/2009 | CN101381409A N-terminally chemically modified protein compositions and methods |
| 03/11/2009 | CN101381367A 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt, hydrate as pharmaceutical |
| 03/11/2009 | CN101381366A Benzimidazole derivative and its use as a ii receptor antagonist |